HCM
EVH icon

HMS Capital Management’s Evolent Health EVH Stock Holding History

HMS Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,569
Closed -$202K – 110
2024
Q2 		$202K Buy
10,569
+3,150
+42% +$80.4K 0.11% 107
2024
Q1 		$243K Buy
7,419
+538
+8% +$17.2K 0.13% 100
2023
Q4 		$227K Sell
6,881
-2,195
-24% -$62.1K 0.14% 101
2023
Q3 		$247K Sell
9,076
-976
-10% -$27.1K 0.16% 99
2023
Q2 		$305K Buy
10,052
+131
+1% +$4.24K 0.19% 96
2023
Q1 		$322K Buy
+9,921
New +$314K 0.2% 85
2022
Q4 		– Sell
-8,927
Closed -$321K – 102
2022
Q3 		$321K Sell
8,927
-181
-2% -$6.38K 0.19% 86
2022
Q2 		$280K Buy
+9,108
New +$265K 0.14% 98

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

HMS Capital Management's EVH Position: Q3 2024 in Review

HMS Capital Management sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 10,569 shares — an estimated $202K sold.

HMS Capital Management first reported a position in EVH in Q2 2022 and held it in 8 quarters. The position peaked at $322K in Q1 2023. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • HMS Capital Management reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • HMS Capital Management sold 10,569 Evolent Health shares in Q3 2024, an estimated $202K.
  • HMS Capital Management first reported a position in Evolent Health in Q2 2022 and held it in 8 quarters.
  • HMS Capital Management's Evolent Health position peaked at $322K in Q1 2023.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on HMS Capital Management's 13F filing for Q3 2024, filed 30 Oct 2024.